Martha A Schalla1, Andreas Stengel2,3. 1. Charité Center for Internal Medicine and Dermatology, Charité Center for Internal Medicine and Dermatology, Department for Psychosomatic Medicine; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. 2. Charité Center for Internal Medicine and Dermatology, Charité Center for Internal Medicine and Dermatology, Department for Psychosomatic Medicine; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. andreas.stengel@med.uni-tuebingen.de. 3. Department of Psychosomatic Medicine and Psychotherapy, Medical University Hospital Tübingen, Tübingen, Germany. andreas.stengel@med.uni-tuebingen.de.
Abstract
PURPOSE OF REVIEW: Obesity is affecting over 600 million adults worldwide and has numerous negative effects on health. Since ghrelin positively regulates food intake and body weight, targeting its signaling to induce weight loss under conditions of obesity seems promising. Thus, the present work reviews and discusses different possibilities to alter ghrelin signaling. RECENT FINDINGS: Ghrelin signaling can be altered by RNA Spiegelmers, GHSR/Fc, ghrelin-O-acyltransferase inhibitors as well as antagonists, and inverse agonists of the ghrelin receptor. PF-05190457 is the first inverse agonist of the ghrelin receptor tested in humans shown to inhibit growth hormone secretion, gastric emptying, and reduce postprandial glucose levels. Effects on body weight were not examined. Although various highly promising agents targeting ghrelin signaling exist, so far, they were mostly only tested in vitro or in animal models. Further research in humans is thus needed to further assess the effects of ghrelin antagonism on body weight especially under conditions of obesity.
PURPOSE OF REVIEW: Obesity is affecting over 600 million adults worldwide and has numerous negative effects on health. Since ghrelin positively regulates food intake and body weight, targeting its signaling to induce weight loss under conditions of obesity seems promising. Thus, the present work reviews and discusses different possibilities to alter ghrelin signaling. RECENT FINDINGS:Ghrelin signaling can be altered by RNA Spiegelmers, GHSR/Fc, ghrelin-O-acyltransferase inhibitors as well as antagonists, and inverse agonists of the ghrelin receptor. PF-05190457 is the first inverse agonist of the ghrelin receptor tested in humans shown to inhibit growth hormone secretion, gastric emptying, and reduce postprandial glucose levels. Effects on body weight were not examined. Although various highly promising agents targeting ghrelin signaling exist, so far, they were mostly only tested in vitro or in animal models. Further research in humans is thus needed to further assess the effects of ghrelin antagonism on body weight especially under conditions of obesity.
Authors: William P Esler; Joachim Rudolph; Thomas H Claus; Weifeng Tang; Nicole Barucci; Su-Ellen Brown; William Bullock; Michelle Daly; Lynn Decarr; Yaxin Li; Lucinda Milardo; David Molstad; Jian Zhu; Stephen J Gardell; James N Livingston; Laurel J Sweet Journal: Endocrinology Date: 2007-07-26 Impact factor: 4.736
Authors: Eric P Zorrilla; Shinichi Iwasaki; Jason A Moss; Jason Chang; Jonathan Otsuji; Koki Inoue; Michael M Meijler; Kim D Janda Journal: Proc Natl Acad Sci U S A Date: 2006-08-04 Impact factor: 11.205
Authors: A M Wren; L J Seal; M A Cohen; A E Brynes; G S Frost; K G Murphy; W S Dhillo; M A Ghatei; S R Bloom Journal: J Clin Endocrinol Metab Date: 2001-12 Impact factor: 5.958
Authors: Marcin Rucinski; Agnieszka Ziolkowska; Marta Szyszka; Anna Hochol; Ludwik K Malendowicz Journal: Peptides Date: 2012-04-17 Impact factor: 3.750
Authors: Jesus A Gutierrez; Patricia J Solenberg; Douglas R Perkins; Jill A Willency; Michael D Knierman; Zhaoyan Jin; Derrick R Witcher; Shuang Luo; Jude E Onyia; John E Hale Journal: Proc Natl Acad Sci U S A Date: 2008-04-28 Impact factor: 11.205
Authors: Gianfabio Giorgioni; Fabio Del Bello; Wilma Quaglia; Luca Botticelli; Carlo Cifani; E Micioni Di Bonaventura; M V Micioni Di Bonaventura; Alessandro Piergentili Journal: J Med Chem Date: 2022-02-14 Impact factor: 7.446
Authors: Lola J Torz; Sherri Osborne-Lawrence; Juan Rodriguez; Zhenyan He; María Paula Cornejo; Emilio Román Mustafá; Chunyu Jin; Natalia Petersen; Morten A Hedegaard; Maja Nybo; Valentina Martínez Damonte; Nathan P Metzger; Bharath K Mani; Kevin W Williams; Jesica Raingo; Mario Perello; Birgitte Holst; Jeffrey M Zigman Journal: Mol Metab Date: 2020-04-24 Impact factor: 7.422